Mutations in aceK, the gene encoding isocitrate dehydrogenase kinase/phosphatase, which selectively inhibit phosphatase activity have been isolated. These mutations yield amino acid substitutions within a 113-residue region of this 578-residue protein. These mutations may define a regulatory domain of this protein.In Escherichia coli, the Krebs cycle enzyme isocitrate dehydrogenase (IDH) is regulated by reversible phosphorylation (1, 3). The phosphorylation of IDH controls the partitioning of isocitrate between the Krebs cycle and the glyoxylate bypass. The flow of isocitrate through this bypass is essential for growth on acetate, since it avoids the quantitative loss of the acetate carbons as CO2 in the Krebs cycle (6, 7). During growth on acetate, ca. 70% of the IDH is maintained in the inactive, phosphorylated form, forcing isocitrate through the glyoxylate bypass (2,8,11,13, 14). In most genetic backgrounds, phosphorylation of IDH appears to be essential for use of the glyoxylate bypass, since mutations which eliminate IDH kinase prevent growth on acetate (13).The phosphorylation and dephosphorylation of IDH are catalyzed by a bifunctional protein, IDH kinase/phosphatase, expressed from the aceK gene (5, 9, 10). The IDH kinase and IDH phosphatase reactions appear to occur at the same active site, a conclusion supported by the observation that a mutation at the consensus ATP binding site eliminates both activities (18).One of the approaches which we have taken to examine the structure of IDH kinase/phosphatase has been the random mutagenesis of aceK, the gene which encodes this protein. Our strategy has been to screen for alleles which have lost the ability to complement a null mutation in aceK and then assay the products of these candidate alleles for IDH kinase and IDH phosphatase activities. In a previous report (4), we described the isolation of two alleles of aceK (aceK3 and aceK4) whose products retain IDH kinase activity but have suffered drastic reductions in their IDH phosphatase activities. We have subsequently isolated three additional alleles whose products have similar defects (Table 1). Four of these alleles (aceK3, aceK4, aceKS, and aceK7) were generated by replication of a plasmid bearing aceK+ in the mutator strain W3550 (mutD5) (15). To increase the range of possible mutations, we have also employed chemical mutagenesis with hydroxylamine (16). This method resulted in the generation of an additional allele whose product has selectively lost IDH phosphatase activity, aceK6. In order to ensure that each allele had resulted from a single point mutation, we employed relatively mild conditions for mutagenesis. Replication in strain W3550 yielded 0.3% noncomplementing alleles, while treatment with hy-* Corresponding author. droxylamine generated these alleles in only 0.1% of transformants.The locations of the mutations were approximated by testing the abilities of fragments of aceK+ to direct repair of these mutations (17). In this procedure, each mapping plasmid (which carries a fragment of aceK...